Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer susceptibility

World Journal of Gastroenterology

Volumn 20, Issue 32, 2014, Pages 11429-11438

  Xia, Lei Zhou ^a   Liu, Yi ^b   Xu, Xiao Zhou ^c   Jiang, Peng Cheng ^a   Ma, Gui ^a   Bu, Xue Feng ^a   Zhang, Yong Jun ^a   Yu, Feng ^a   Xu, Ke Sen ^b   Li, Hua ^a  

^a JIANGSU UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; Meta analysis; Methylenetetrahydrofolate reductase; Polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MTHFR PROTEIN, HUMAN;

ARTICLE; CANCER SUSCEPTIBILITY; CARDIA; ETHNICITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MODEL; GENOTYPE; HUMAN; META ANALYSIS; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; SYSTEMATIC REVIEW; ENZYMOLOGY; ETHNOLOGY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; PATHOLOGY; PHENOTYPE; PROTECTION; RISK; RISK ASSESSMENT; RISK FACTOR; STOMACH TUMOR;

GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; PROTECTIVE FACTORS; RISK ASSESSMENT; RISK FACTORS; STOMACH NEOPLASMS;

EID: 84909595144     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i32.11429     Document Type: Article

References (47)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID: 21296855 DOI: 10.3322/caac.20107]
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917 [PMID: 21351269 DOI: 10.1002/ijc.25516]
3. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006; 12: 354-362 [PMID: 16489633]
4. Muñoz N, Franceschi S. Epidemiology of gastric cancer and perspectives for prevention. Salud Publica Mex 1997; 39: 318-330 [PMID: 9337564 DOI: 10.1590/S0036-36341997000400010]
5. Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG, Rozen R. Human methylenetetrahydrofolate reductase: isolation of cDNA mapping and mutation identification. Nat Genet 1994; 7: 551 [PMID: 7951330 DOI: 10.1038/ng0694-195]
6. Rozen R. Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR). Thromb Haemost 1997; 78: 523-526 [PMID: 9198208]
7. Kim YI. Methylenetetrahydrofolate reductase polymorphisms, folate, and cancer risk: a paradigm of gene-nutrient interactions in carcinogenesis. Nutr Rev 2000; 58: 205-209 [PMID: 10941256 DOI: 10.1111/j.1753-4887.2000.tb01863.x]
8. Stern LL, Mason JB, Selhub J, Choi SW. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev 2000; 9: 849-853 [PMID: 10952104]
9. van der Put NM, Gabreëls F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP, Blom HJ. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998; 62: 1044-1051 [PMID: 9545395 DOI: 10.1086/301825]
10. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-113 [PMID: 7647779 DOI: 10.1038/ng0595-111]
11. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998; 64: 169-172 [PMID: 9719624 DOI: 10.1006/mgme.1998.2714]
12. Gao S, Ding LH, Wang JW, Li CB, Wang ZY. Diet folate, DNA methylation and polymorphisms in methylenetetrahydrofolate reductase in association with the susceptibility to gastric cancer. Asian Pac J Cancer Prev 2013; 14: 299-302 [PMID: 23534741 DOI: 10.7314/APJCP.2013.14.1.299]
13. Guo W, Chen P, Zheng LH, Li S. Association between methylenetetrahydrofolate reductase gene polymorphisms (C677T and G1793A) and risk of gastric cancer. Shijie Huaren Xiaohua Zazhi 2012; 20: 690-693
14. Saberi S, Zendehdel K, Jahangiri S, Talebkhan Y, Abdirad A, Mohajerani N, Bababeik M, Karami N, Esmaili M, Oghalaie A, Hassanpour P, Amini N, Mohagheghi MA, Eshagh Hossieni M, Mohammadi M. Impact of methylenetetrahydrofolate reductase C677T polymorphism on the risk of gastric cancer and its interaction with Helicobacter pylori infection. Iran Biomed J 2012; 16: 179-184 [PMID: 23183616]
15. Yang XX, Li F, Yi JP, Li X, Sun JZ, Hu NY. Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric, colorectal and lung cancer. Guangdong Yixue 2010; 31: 2375-2378
16. Cui LH, Shin MH, Kweon SS, Kim HN, Song HR, Piao JM, Choi JS, Shim HJ, Hwang JE, Kim HR, Park YK, Kim SH. Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric and colorectal cancer in a Korean population. BMC Cancer 2010; 10: 236 [PMID: 20504332 DOI: 10.1186/1471-2407-10-236]
17. De Re V, Cannizzaro R, Canzonieri V, Cecchin E, Caggiari L, De Mattia E, Pratesi C, De Paoli P, Toffoli G. MTHFR polymorphisms in gastric cancer and in first-degree relatives of patients with gastric cancer. Tumour Biol 2010; 31: 23-32 [PMID: 20237899 DOI: 10.1007/s13277-009-0004-1]
18. Galván-Portillo MV, Cantoral A, Oñate-Ocaña LF, Chen J, Herrera-Goepfert R, Torres-Sanchez L, Hernandez-Ramirez RU, Palma-Coca O, López-Carrillo L. Gastric cancer in relation to the intake of nutrients involved in one-carbon metabolism among MTHFR 677 TT carriers. Eur J Nutr 2009; 48: 269-276 [PMID: 19288150 DOI: 10.1007/s00394-009-0010-5]
19. Götze T, Röcken C, Röhl FW, Wex T, Hoffmann J, Westphal S, Malfertheiner P, Ebert MP, Dierkes J. Gene polymorphisms of folate metabolizing enzymes and the risk of gastric cancer. Cancer Lett 2007; 251: 228-236 [PMID: 17208363 DOI: 10.1016/j.canlet.2006.11.021]
20. Zeybek U, Yaylim I, Yilmaz H, Aʇac¸han B, Ergen A, Arikan S, Bayrak S, Isbir T. Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric and colorectal cancer. Cell Biochem Funct 2007; 25: 419-422 [PMID: 16927418 DOI: 10.1002/cbf.1317]
21. Vollset SE, Igland J, Jenab M, Fredriksen A, Meyer K, Eussen S, Gjessing HK, Ueland PM, Pera G, Sala N, Agudo A, Capella G, Del Giudice G, Palli D, Boeing H, Weikert C, Bueno-de-Mesquita HB, Carneiro F, Pala V, Vineis P, Tumino R, Panico S, Berglund G, Manjer J, Stenling R, Hallmans G, Martínez C, Dorronsoro M, Barricarte A, Navarro C, Quirós JR, Allen N, Key TJ, Bingham S, Linseisen J, Kaaks R, Overvad K, Tjønneland A, Büchner FL, Peeters PH, Numans ME, Clavel-Chapelon F, Boutron-Ruault MC, Trichopoulou A, Lund E, Slimani N, Ferrari P, Riboli E, González CA. The association of gastric cancer risk with plasma folate, cobalamin, and methylenetetrahydrofolate reductase polymorphisms in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 2007; 16: 2416-2424 [PMID: 18006931 DOI: 10.1158/1055-9965.EPI-07-0256]
22. Mu LN, Cao W, Zhang ZF, Yu SZ, Jiang QW, You NC, Lu QY, Zhou XF, Ding BG, Chang J, Chen CW, Wei GR, Cai L. Polymorphisms of 5,10-methylenetetralydrofolate reductase (MTHFR), fruit and vegetable intake, and the risk of stomach cancer. Biomarkers 2007; 12: 61-75 [PMID: 17438654 DOI: 10.1080/13547500600945101]
23. Zhang FF, Terry MB, Hou L, Chen J, Lissowska J, Yeager M, Zatonski W, Chanock S, Morabia A, Chow WH. Genetic polymorphisms in folate metabolism and the risk of stomach cancer. Cancer Epidemiol Biomarkers Prev 2007; 16: 115-121 [PMID: 17220339 DOI: 10.1158/1055-9965.EPI-06-0513]
24. Boccia S, Gianfagna F, Persiani R, La Greca A, Arzani D, Rausei S, D'ugo D, Magistrelli P, Villari P, Van Duijn CM, Ricciardi G. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and susceptibility to gastric adenocarcinoma in an Italian population. Biomarkers 2007; 12: 635-644 [PMID: 17972183 DOI: 10.1371/journal.pone.0088242]
25. Fu G, Yang FY, Shen XB, PU YP, Zhang J. Relationship between the Methylenetetrahydrofolate Reductase A1298C Genetic Polymorphisms and Susceptibility to Gastric Cancer. J Environ Occup Med 2007; 24: 32-35
26. Graziano F, Kawakami K, Ruzzo A, Watanabe G, Santini D, Pizzagalli F, Bisonni R, Mari D, Floriani I, Catalano V, Silva R, Tonini G, Torri V, Giustini L, Magnani M. Methylenetetrahydrofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at-risk Italian population. Int J Cancer 2006; 118: 628-632 [PMID: 16094648 DOI: 10.1002/ijc.21397]
27. Li S, Cai MJ, Hou P, He NY. Single nucleotide polymorphisms (C677T and A1298C) in methylenetetrahy 2 drofolate reductase gene and suscepcipility to gastric carcinoma. Dongnan Daxue Xuebao 2006; 25: 321-324
28. Weng YR, Sun DF, Fang JY, Gu WQ, Zhu HY. Folate levels in mucosal tissue but not methylenetetrahydrofolate reductase polymorphisms are associated with gastric carcinogenesis. World J Gastroenterol 2006; 12: 7591-7597 [PMID: 17171786]
29. Kim JK, Kim S, Han JH, Kim HJ, Chong SY, Hong SP, Hwang SG, Ahn JY, Cha KY, Oh D, Kim NK. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of stomach cancer in a Korean population. Anticancer Res 2005; 25: 2249-2252 [PMID: 16158971]
30. Si PR, Fang DC, Zhang H, Yang LQ, Luo YH, Liao HY. The relationship between metbylenetetrahydrofolate reductase gene polymorphism and microsatellite instability in gastric cancer. Zhonghua Liuxingbing Zazhi 2005; 26: 794-799
31. Sarbia M, Geddert H, Kiel S, Kandemin Y, Schulz WA, Vossen S, Zotz RD, Willers R, Baldus SE, Schneider PM, Gabbert HE. Methylenetetrahydrofolate reductase C677T polymorphism and risk of adenocarcinoma of the upper gastrointestinal tract. Scand J Gastroenterol 2005; 40: 109-111 [PMID: 15841723 DOI: 10.1080/00365520410009500]
32. Bi JP, Cai L, Zheng ZL. Study on C667T gene polymorphism and susceptibility to gastric cancer. Zhongguo Gonggong Weisheng 2005; 21: 661-663
33. Wang LD, Guo RF, Fan ZM, He X, Gao SS, Guo HQ, Matsuo K, Yin LM, Li JL. Association of methylenetetrahydrofolate reductase and thymidylate synthase promoter polymorphisms with genetic susceptibility to esophageal and cardia cancer in a Chinese high-risk population. Dis Esophagus 2005; 18: 177-184 [PMID: 16045580 DOI: 10.1111/j.1442-2050.2005.00492.x]
34. Stolzenberg-Solomon RZ, Qiao YL, Abnet CC, Ratnasinghe DL, Dawsey SM, Dong ZW, Taylor PR, Mark SD. Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev 2003; 12: 1222-1226 [PMID: 14652285]
35. Miao X, Xing D, Tan W, Qi J, Lu W, Lin D. Susceptibility to gastric cardia adenocarcinoma and genetic polymorphisms in methylenetetrahydrofolate reductase in an at-risk Chinese population. Cancer Epidemiol Biomarkers Prev 2002; 11: 1454-1458 [PMID: 12433726]
36. Gao CM, Wu JZ, Ding JH, Liu YT, Zang Y, Li SP, Su P, Hu X, Xu TL. Polymorphisms of methylenetetrahydrofolate reductase C677T and the risk of stomach cancer. Zhonghua Liuxingbing Zazhi 2002; 23: 289-292
37. Shen H, Xu Y, Zheng Y, Qian Y, Yu R, Qin Y, Wang X, Spitz MR, Wei Q. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study. Int J Cancer 2001; 95: 332-336 [PMID: 11494235 DOI: 10.1002/1097-0215(20010920)95]
38. Dong X, Wu J, Liang P, Li J, Yuan L, Liu X. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer: a meta-analysis. Arch Med Res 2010; 41: 125-133 [PMID: 20470942 DOI: 10.1016/j.arcmed.2010.01.001]
39. Boccia S, Hung R, Ricciardi G, Gianfagna F, Ebert MP, Fang JY, Gao CM, Götze T, Graziano F, Lacasaña-Navarro M, Lin D, López-Carrillo L, Qiao YL, Shen H, Stolzenberg-Solomon R, Takezaki T, Weng YR, Zhang FF, van Duijn CM, Boffetta P, Taioli E. Meta- and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC review. Am J Epidemiol 2008; 167: 505-516 [PMID: 18162478 DOI: 10.1093/aje/kwm344]
40. Zintzaras E. Association of methylenetetrahydrofolate reductase (MTHFR) polymorphisms with genetic susceptibility to gastric cancer: a meta-analysis. J Hum Genet 2006; 51: 618-624 [PMID: 16758123 DOI: 10.1007/s10038-006-0405-6]
41. Larsson SC, Giovannucci E, Wolk A. Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. Gastroenterology 2006; 131: 1271-1283 [PMID: 17030196 DOI: 10.1053/j.gastro.2006.08.010]
42. Lv L, Wang P, Sun B, Chen G. The polymorphism of methylenetetrahydrofolate reductase C677T but not A1298C contributes to gastric cancer. Tumour Biol 2014; 35: 227-237 [PMID: 23897558 DOI: 10.1007/s13277-013-1028-0]
43. Zacho J, Yazdanyar S, Bojesen SE, Tybjærg-Hansen A, Nordestgaard BG. Hyperhomocysteinemia, methylenetetrahydrofolate reductase c.677C > T polymorphism and risk of cancer: cross-sectional and prospective studies and meta-analyses of 75,000 cases and 93,000 controls. Int J Cancer 2011; 128: 644-652 [PMID: 20473868 DOI: 10.1002/ijc.25375]
44. Yan S, Xu D, Wang P, Wang P, Liu C, Hua C, Jiang T, Zhang B, Li Z, Lu L, Liu X, Wang B, Zhang D, Zhang R, He S, Sun B, Wang X. MTHFR C677T polymorphism contributes to the risk for gastric cancer. Tumour Biol 2014; 35: 2123-2132 [PMID: 24122207 DOI: 10.1007/s13277-013-1282-1]
45. Solomon E, Borrow J, Goddard AD. Chromosome aberrations and cancer. Science 1991; 254: 1153-1160 [PMID: 1957167 DOI: 10.1126/science.1957167]
46. Laird PW, Jaenisch R. The role of DNA methylation in cancer genetic and epigenetics. Annu Rev Genet 1996; 30: 441-464 [PMID: 8982461 DOI: 10.1146/annurev.genet.30.1.441]
47. Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 2000; 151: 862-877 [PMID: 10791559 DOI: 10.1093/oxfordjournals.aje.a010290]